• 1
    >American Cancer Society. Cancer facts and figures 2001. Atlanta: American Cancer Society, 2001.
  • 2
    Scherr PA, Mueller NE. Non-Hodgkin's lymphomas. In: SchottenfeldD, FraumeniJF, editors. Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996: 920945.
  • 3
    Devesa SS, Fears T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res. 1992; 52: 5432s5440s.
  • 4
    Zheng T, Mayne ST, Boyle P, Holford TR, Liu WL, Flannery J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935–1988. Cancer. 1992;70: 840849.
  • 5
    Hartge P, Devesa SS, Fraumeni JF Jr. Hodgkin's and non-Hodgkin's lymphomas. Cancer Surveys. 1994; 1920: 423–453.
  • 6
    Holford TR, Zheng T, Mayne ST, McKay LA. Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res. 1992;52: 5443s5446s.
  • 7
    Palackdharry CS. The epidemiology of non-Hodgkin's lymphoma: why the increased incidence? Oncology. 1994; 8: 6773; discussion 73–78.
  • 8
    Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 2001; 93: 824842.
  • 9
    Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973–1998. Bethesda: National Cancer Institute, 2001.
  • 10
    Harnly ME, Swan SH, Holly EA, Kelter A, Padian N. Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immunodeficiency syndrome (AIDS). Am J Epidemiol. 1988; 128: 261267.
  • 11
    Clarke CA. Changing incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among young men in San Francisco. AIDS. 2001; 15: 19131915.
  • 12
    McKean-Cowdin R, Feigelson HS, Ross RK, Pike MC, Henderson BE. Declining cancer rates in the 1990s. J Clin Oncol. 2000; 18: 22582268.
  • 13
    Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000; 92: 12401251.
  • 14
    Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999; 17: 38353849.
  • 15
    Herrinton LJ. Epidemiology of the Revised European–American Lymphoma Classification subtypes. Epidemiol Rev. 1998; 20: 187203.
  • 16
    National Cancer Institute. The SEER Program code manual. Bethesda: National Cancer Institute, 1999.
  • 17
    Percy C, Van Holten V, Muir C. International classification of diseases for oncology. Geneva: World Health Organization, 1990.
  • 18
    National Cancer Institute. SEER*Stat 4.0 ed. Silver Spring: Information Management Services, Inc., 2001.
  • 19
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335351.
  • 20
    National Cancer Institute. Joinpoint regression program, version 2.3, 2.3 ed. Bethesda: National Cancer Institute, 2000.
  • 21
    Devesa SS, Donaldson J, Fears T. Graphical presentation of trends in rates. Am J Epidemiol. 1995; 141: 300304.
  • 22
    Ries LAG, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program, 1975–1995 edition. NIH publication 99-4649. Bethesda: National Institutes of Health, 1999.
  • 23
    Linet MS, Ries LA, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst. 1999; 91: 10511058.
  • 24
    Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Atlanta: CDC, 1999.
  • 25
    Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med. 1996;334: 10111017.
  • 26
    Moore RD, Chaisson RE. Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS. 1999; 13: 19331942.
  • 27
    McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS. 1999;13: 16871695.
  • 28
    Grulich AE, Wan X, Law MG, et al. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS. AIDS. 2000; 14: 133140.
  • 29
    Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J AIDS Hum Retrovirol. 1999; 21(Suppl 1): S27S30.
  • 30
    Biggar RJ, Rosenberg PS, Cote TR. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS: the Multistate AIDS/Cancer Match Study Group. Int J Cancer. 1996; 68: 754758.
  • 31
    Haverkos HW, Turner JF Jr., Moolchan ET, Cadet JL. Relative rates of AIDS among racial/ethnic groups by exposure categories. J Natl Med Assoc. 1999;91: 1724.
  • 32
    Centers for Disease Control and Prevention. Diagnosis and reporting of HIV and AIDS in states with integrated HIV and AIDS surveillance—United States, January 1994-June 1997. MMWR. 1998; 47: 309314.
  • 33
    Davis SF, Rosen DH, Steinberg S, Wortley PM, Karon JM, Gwinn M. Trends in HIV prevalence among childbearing women in the United States, 1989–1994. J AIDS Hum Retrovirol. 1998; 19: 158164.
  • 34
    Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J AIDS Hum Retrovirol. 1998; 17: 253261.
  • 35
    McNally RJ, Roman E, Cartwright RA. Leukemias and lymphomas: time trends in the UK, 1984–1993. Cancer Causes Control. 1999; 10: 3542.
  • 36
    Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer. 2000; 88: 23982424.
  • 37
    Nelson RA, Levine AM, Marks G, Bernstein L. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma. Br J Cancer. 1997; 76: 15321537.
  • 38
    Zahm SH, Weisenburger DD, Holmes FF, Cantor KP, Blair A. Tobacco and non-Hodgkin's lymphoma: combined analysis of three case-control studies (United States). Cancer Causes Control. 1997; 8: 159166.
  • 39
    Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 1998; 7: 2528.
  • 40
    Holly EA, Lele C, Bracci PM, McGrath MS. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol. 1999; 150: 375389.
  • 41
    Parker AS, Cerhan JR, Dick F, et al. Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women. Leuk Lymphoma. 2000; 37: 341349.
  • 42
    Dalton SO, Johansen C, Mellemkjaer L, et al. Antidepressant medications and risk for cancer. Epidemiology. 2000; 11: 171176.
  • 43
    Shahar E, Folsom AR, Romm FJ, et al. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1996; 131: 915922.
  • 44
    Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A. Cancer and diabetes—a follow-up study of two population-based cohorts of diabetic patients. J Intern Med. 1997; 241: 471475.
  • 45
    Cerhan JR, Wallace RB, Folsom AR, et al. Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst. 1997; 89: 314318.
  • 46
    Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999; 282: 15191522.
  • 47
    Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23: 12781283.
  • 48
    Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J. Lymphoma classification—from controversy to consensus: the R.E.A.L. and WHO classification of lymphoid neoplasms. Ann Oncol. 2000;11(Suppl 1): 310.